Hypertensive Disorder of Pregnancy Clinical Trial
Official title:
Intensive Postpartum Antihypertensive Treatment to Improve Women's Cardiovascular Health (IPAT Study)
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
The IPAT will randomize 60 postpartum patients with HDP at the Medical College of Wisconsin (MCW) to intensive BP control with Nifedipine extended release (ER) (target BP <140/90 mmHg) versus usual care (target BP <160/110 mmHg). Oversampling of Black patients with HDP will be done to ensure they comprise 50% of study participants. Patients enrolled in both arms will undergo education on healthy lifestyle following AHA "Life's Essential 8" (LE8) of tobacco cessation, physical activity, healthy sleep, and healthy diet with detailed overview of DASH throughout the first year postpartum with monthly virtual educational session delivered by a registered dietician and a life coach. Assessment of LE8 CVH score will be done after delivery, 6 weeks postpartum, and 12 months postpartum. Participants will also undergo vascular function assessment: endothelial dysfunction with brachial artery flow mediated dilation (FMD), arterial stiffness with carotid-femoral pulse wave velocity (cfPWV) and anti-angiogenic and inflammatory CVD biomarker with soluble fms-like tyrosine kinase (sFlt-1), at baseline, 6 weeks, and 12 months postpartum. The primary outcome is feasibility of all study procedures, including recruitment, retention, and adherence. Secondary outcomes are change in BP, CVH score, FMD, PWV, and sFlt-1 from baseline to 12 months postpartum. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05999851 -
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT02020174 -
The Preeclampsia Registry
|
||
Recruiting |
NCT06377878 -
The Preeclampsia Registry
|
||
Recruiting |
NCT05995106 -
mHealth for Hypertensive Disorder of Pregnancy
|
N/A | |
Completed |
NCT03309826 -
Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy
|
N/A | |
Completed |
NCT05631067 -
Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality
|
N/A | |
Completed |
NCT03412552 -
Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia
|
N/A | |
Completed |
NCT03728790 -
Remote BP Monitoring in the PP Period
|
N/A | |
Recruiting |
NCT05089175 -
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
|
||
Enrolling by invitation |
NCT05763069 -
HOME: Home Monitoring of High-risk Pregnancies
|
||
Recruiting |
NCT06069102 -
Optimal Blood Pressure Treatment Thresholds Postpartum
|
Phase 4 | |
Recruiting |
NCT05659173 -
Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension
|
||
Recruiting |
NCT06281665 -
Treatment With Aspirin After Preeclampsia: TAP Trial
|
Phase 4 | |
Completed |
NCT05124327 -
Remote Monitoring and Follow-up for Postpartum Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT06362356 -
Microbial Metabolites and Outcomes of Pregnancy Study
|
||
Active, not recruiting |
NCT04580927 -
Breastfeeding and Postpartum Cardiovascular Health
|
N/A | |
Recruiting |
NCT05655936 -
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
|
N/A | |
Enrolling by invitation |
NCT05835596 -
MumCare: Mum's Cardiovascular Health for Life
|
N/A | |
Completed |
NCT06019715 -
Remote Postpartum Intervention Targeting Movement Behaviors After Hypertensive Disorders of Pregnancy
|
N/A | |
Not yet recruiting |
NCT06220721 -
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
|
Phase 3 |